Morningstar has combed its databases and analyzed the numbers. Here's where women stand in the industry today.
As the real estate cycle nears its end, long-term opportunities remain.
Innovation and M&A may drive these firms' fortunes.
Morningstar experts discuss patient benefits, costs, and planning for healthcare amid accelerating technology.
Emmanuel Roman asserts his firm's fixed-income edge at the Morningstar Investment Conference.
Morningstar’s Seth Goldstein on what’s driving adoption worldwide and which companies stand to benefit.
At Aristotle, the emphasis is on long-term ownership.
Ariel's Rupal Bhansali on the rewards of reining in risk.
Boutique buys businesses run by managers who have skin in the game.
Vanguard’s Gemma Wright-Casparius on TIPS and travel.
Most utilities stocks are still fairly valued, but the market is not recognizing the value of several firms facing headwinds.
Two top stock-pickers shared their strategies for success.
Up-and-coming markets are coming into their own.
Backed by Baird, Chautauqua sticks to what it does best.
Baron’s Cliff Greenberg on small-cap growth investing and a Grateful Dead cover band.
Apparel companies brace for competition.
Industrial distributors stand up to digital competition.
Anne Lester of J.P. Morgan on meeting goals in a muted market.
With increased competition from all corners, consumer defensive companies are cutting costs to offset sluggish growth.
Fidelity Growth Strategies keeps the risks of mid-cap growth investing in check.
There's no maverick manager making heroic bets against a benchmark at Tributary Small Company Fund--just careful work from an experienced team in Omaha.
The winners have emerged in the cloud market.
Perritt's Michael Corbett on micro-cap inefficiencies and opportunities.
Key players in the pharmaceuticals sector are fortifying their moats with emerging immuno-oncology drugs.
These funds offer thoughtful investments in healthcare, not tactical plays.
Dodge & Cox Global Stock and Oakmark Global earn high marks thanks to experienced management, distinctive strategies, and fine long-term performance.
This Gold-rated fund is not a safe choice, but it's a strong one for the right kind of investor.
Many right answers but different investor experiences along the way with a variety of stock/bond asset allocations.
For most funds, a recent upsurge in volatility probably doesn't signal a dramatic departure from established strategies. In some cases, however, there may have been a change for the worse.
Wasatch Core Growth has been upgraded to a Morningstar Analyst Rating of Gold.
The initial data suggests yes, though it's too early to draw hard conclusions.
Manager changes prompt downgrades at two T. Rowe Price funds.
The firm continues to earn advisors' confidence, and strong inflows in 2015 keep it among the 10 largest U.S. fund companies.
These funds have lost less in downturns than the S&P 500.
While Wasatch Core Growth and Conestoga Small Cap both offer downside protection, investors should be aware of their very different sector exposures.
Silver-rated Champlain Mid Cap is a suitable alternative to better-known Champlain Small Company, which is closed.
Seven other Morningstar Medalists are downgraded.
But there were also six downgrades, including three to Neutral.
But passive equity and alternative strategies continue to draw interest.
There were a handful of upgrades and downgrades, and five newly rated Morningstar Medalists.
Silver-rated JPMorgan US Equity is a fine core holding for the domestic-equity portion of a portfolio.
Recent succession planning should protect his legacy and serve shareholders well.
Morningstar's price/fair value measure points to few undervalued options among the best U.S. large-cap funds.
Two recent manager changes at Goldman Sachs illustrate how other factors can mitigate the disruption.
Make sure the dividend a company is paying today isn't coming at the expense of future payouts or the future growth of the business, says Silver-rated JPMorgan Equity Income manager Clare Hart. Plus, the case for domestic tobacco and energy.
Baron Small Cap favors steady growers that can be held for a long time--a strategy that has helped the fund regularly outperform its benchmark as well as its peers.
This young fund comes from a company that is an old Morningstar favorite.
A stretch of bad performance and outflows could offer an attractive chance to get into these top-rated funds.
High outflows, a low cash stake, and accumulated capital gains may create a perfect storm.
This socially responsible portfolio has delivered 5-star performance with below-average expenses and is one of the lowest-risk names in its category.